KRONOS BIO INC. - COM
0.8800
08-十月-24 12:24:53
15 分钟延时
股票
-0.1100
-11.11%
今日范围
0.8520 - 0.9800
ISIN
N/A
来源
NASDAQ
-
12 10月 2022 04:04:45 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in H.C. Wainwright 24th Annual Global Investment Conference
06 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
22 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
16 8月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Second-Quarter 2022 Financial Results
04 8月 2022 16:05:02 条件 Nasdaq GlobeNewswire
-
10 6月 2022 03:04:36 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
01 6月 2022 16:05:01 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in H.C. Wainwright Global Investment Conference
17 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
12 5月 2022 10:23:18 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results
04 5月 2022 16:05:02 条件 Nasdaq GlobeNewswire
-
08 3月 2022 17:08:22 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Cowen 42nd Annual Health Care Conference
01 3月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
24 2月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development
01 2月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
06 12月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Positive Data from Ongoing Phase 1/2 Trial of Oral CDK9 Inhibitor KB-0742
29 11月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
24 11月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Appoints Roshawn Blunt to Board of Directors
11 11月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Third-Quarter Financial Results
09 11月 2021 16:10:42 条件 Nasdaq GlobeNewswire